Feed NEOG
NE

Neogen Corporation

NEOG · NASDAQ

$12.55 +2.03% (+$0.25)
1M +8.47%
Market Cap $2.74B
P/E Ratio -
Div. Yield -
ROE 0.37%
Piotroski F-Score Moderate
6/9
Valuation
32 /100
Expensive
EV/EBITDA 19.44x
P/S 3.14x
P/B 1.31x
Growth
100 /100
Growing
Rev. growth 19.28%
Book val. growth 32.65%
EPS growth N/A
Profitability
28 /100
Weak
Gross margin 46.93%
Net margin 0.91%
Op. margin 2.49%
Quality
4 /100
Poor
ROIC 0.60%
ROE 0.37%
ROA 0.24%
Debt
57 /100
Moderate
Debt/Equity 0.38x
Current ratio 3.82x
Int. coverage 0.85x
Stability
12 /100
Unstable
Beta 1.76x
Rev. volatility 30.70%
EPS volatility 6,600.82%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o NEOG
Online

O podjetju

Neogen Corporation is a global biotechnology company specializing in providing solutions for detecting and preventing risks in food, feed, and healthcare. The company develops and commercializes a wide range of testing products that help protect public health, including tests for detecting pathogens, allergens, mycotoxins, and other contaminants in food. Neogen also provides products for veterinary medicine and pharmaceutical manufacturing, making it a key player in food safety and health risk management.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Mikhael Nassif

Employees

2,636

Headquarters

Lansing

Prihajajoči dogodki

06 OKT.

Earnings

Upcoming earnings report

19d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.